Literature DB >> 32122992

RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis.

Lei Wu1,2, Xiao Zhang1,2, Lu Zheng3, Huakan Zhao1,2, Guifang Yan1,2, Qi Zhang1,2, Yu Zhou1,2, Juan Lei1,2, Jiangang Zhang1,2, Jingchun Wang1,2, Rong Xin1, Lu Jiang1, Jin Peng1, Qian Chen1, Sin Man Lam4,5, Guanghou Shui4, Hongming Miao6, Yongsheng Li7,2.   

Abstract

Metabolic reprogramming is critical for the polarization and function of tumor-associated macrophages (TAM) and hepatocarcinogenesis, but how this reprogramming occurs is unknown. Here, we showed that receptor-interacting protein kinase 3 (RIPK3), a central factor in necroptosis, is downregulated in hepatocellular carcinoma (HCC)-associated macrophages, which correlated with tumorigenesis and enhanced the accumulation and polarization of M2 TAMs. Mechanistically, RIPK3 deficiency in TAMs reduced reactive oxygen species and significantly inhibited caspase1-mediated cleavage of PPAR. These effects enabled PPAR activation and facilitated fatty acid metabolism, including fatty acid oxidation (FAO), and induced M2 polarization in the tumor microenvironment. RIPK3 upregulation or FAO blockade reversed the immunosuppressive activity of TAMs and dampened HCC tumorigenesis. Our findings provide molecular basis for the regulation of RIPK3-mediated, lipid metabolic reprogramming of TAMs, thus highlighting a potential strategy for targeting the immunometabolism of HCC. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32122992     DOI: 10.1158/2326-6066.CIR-19-0261

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  37 in total

Review 1.  Lipid Metabolism in Tumor-Associated Macrophages.

Authors:  Yuancai Xiang; Hongming Miao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity.

Authors:  Stavros P Papadakos; Nikolaos Dedes; Elias Kouroumalis; Stamatios Theocharis
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

3.  Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer.

Authors:  Nan Wang; Yuanting Gu; Lin Li; Jiangrui Chi; Xinwei Liu; Youyi Xiong; Chaochao Zhong
Journal:  J Inflamm Res       Date:  2022-06-14

Review 4.  RIPK3 signaling and its role in the pathogenesis of cancers.

Authors:  Shanhui Liu; Kanak Joshi; Mitchell F Denning; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2021-10-15       Impact factor: 9.207

5.  Metabolism in tumor-associated macrophages.

Authors:  Jie Li; Gina M DeNicola; Brian Ruffell
Journal:  Int Rev Cell Mol Biol       Date:  2022-02-21       Impact factor: 6.420

Review 6.  Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming.

Authors:  Kanchan Vishnoi; Sandeep Kumar; Rong Ke; Ajay Rana; Basabi Rana
Journal:  Curr Opin Pharmacol       Date:  2022-05-05       Impact factor: 4.768

Review 7.  Overview: Lipid Metabolism in the Tumor Microenvironment.

Authors:  Kaili Ma; Lianjun Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Metabolic Regulation of Macrophage Activation.

Authors:  Ourania Kolliniati; Eleftheria Ieronymaki; Eleni Vergadi; Christos Tsatsanis
Journal:  J Innate Immun       Date:  2021-07-09       Impact factor: 7.349

Review 9.  Glucose Metabolism: The Metabolic Signature of Tumor Associated Macrophage.

Authors:  Qi Zhang; Junli Wang; Dipesh Kumar Yadav; Xueli Bai; Tingbo Liang
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

Review 10.  Metabolic Cancer-Macrophage Crosstalk in the Tumor Microenvironment.

Authors:  Kyra E de Goede; Amber J M Driessen; Jan Van den Bossche
Journal:  Biology (Basel)       Date:  2020-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.